Generic drug sector is strong, Chengda Pharmaceutical leads in gains

2026-04-02 02:23:25

Abstract generation in progress

April 1 news, as of 13:50, the generic drugs sector is strong. BeiDa Pharmaceutical has hit the daily limit. Chengda Pharmaceutical, U-Sort Biopharma, Wantbon Biopharmaceutical, Jingxin Pharmaceutical, Xinlaitai, Tigermed, Haisun Pharmaceutical, Changshan Pharmaceutical, and other individual stocks are leading with gains.

Statement: The market involves risk; investing requires caution. This article is automatically published based on a third-party database and does not represent the opinions of Sina Finance. Any information appearing in this article is for reference only and does not constitute personal investment advice. In case of any discrepancy, please refer to the actual announcements. If you have any questions, please contact biz@staff.sina.com.cn.

Massive information, precise analysis—available in the Sina Finance app

Responsible editor: Xiaolang Express

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes